Key result
In a systematic review of 32 cases, treatment with other therapies showed no difference in recurrence or metastasis compared to no other therapies for undifferentiated pleomorphic sarcoma of the chest.
Why the study?
Undifferentiated pleomorphic sarcoma is commonly found in the extremities, making trunk and chest wall presentations rare, complex to treat, and in need of systematic characterization.
What are the patient characteristics, outcomes, and best treatment modalities for undifferentiated pleomorphic sarcoma of the chest wall?
Systematic Review (n=32)
What are the patient characteristics, outcomes, and best treatment modalities for undifferentiated pleomorphic sarcoma of the chest wall?
Undifferentiated pleomorphic sarcoma of the chest wall is a rare condition that is more common in women, with current case report data showing no significant difference in recurrence or metastasis with adjunctive therapies.
This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Undifferentiated pleomorphic sarcoma (UPS) accounts for approximately 15% of all soft-tissue sarcoma (STS) cases and have a 5-year survival prognosis of around 60%. Due to its complexity, tumors are often identified by clinical and pathological exclusion. UPS is commonly found in the extremities, so finding them in the trunk and chest wall is rare. The primary objectives of this systematic review are: (I) identifying patient characteristics with lesion; (II) compiling patient outcomes following surgery; (III) identifying best therapy modalities; (IV) characterizing reported lesion histology; (V) assessing current surgical recommendations for resection; (VI) classifying lesions and their association with radiation. METHODS: The PRISMA framework was utilized to identify case reports and records providing information on UPS in the chest wall. Case reports and articles were screened for relevance, full-text accessibility, and if they contained the terms ("undifferentiated pleomorphic sarcoma", "breast", "chest wall", or "trunk") in their title or abstract. The PubMed database was the primary database, and the search criteria was "(undifferentiated pleomorphic sarcoma) AND ((breast) OR (trunk) OR (chest) OR (chest wall))" from 01/01/2003 to 05/21/2023. Given that these were case reports, bias risk and heterogeneity was not assessed due to its difficulty. Information from case reports were compiled into a table and a Chi-squared test was performed, but no meta-analysis was completed. RESULTS: Of 433 studies, 24 case reports and 22 records were selected to inform on UPS in the chest wall. The 24 case reports yielded 32 cases providing information on patient outcomes, tumor characteristics, and treatment. A meta-analysis was not performed, but literature was summarized to inform on treating the condition. Case reports were compiled into a table providing information on patient age, gender, tumor location, treatment modalities, margin distance, and other factors. CONCLUSIONS: Treatment of UPS involving the chest is extremely complex. Unlike typical UPS, it is more often found in women than in men, which is corroborated by the results of this study. This study also notes no difference in recurrence or metastasis between patient who were treated and those who were not treated with other therapies.
Answers are grounded in this paper and cite their sources.
Chest wall UPS shows female predominance without adjuvant therapy benefit; leaves open optimal management pending prospective studies.
No takes yet. Share an insight, caveat, or question.
Bennett et al. (2023) conducted a systematic review in Undifferentiated pleomorphic sarcoma (UPS) of the chest wall (n=32). Other therapies (adjunct to surgery) vs. No other therapies was evaluated on Recurrence or metastasis. In a systematic review of 32 cases, treatment with other therapies showed no difference in recurrence or metastasis compared to no other therapies for undifferentiated pleomorphic sarcoma of the chest.
Synapse has enriched 10 related papers. Consider them for comparative context: